Katrina Thornber, Author at European Medical Journal - Page 33 of 35

Researchers Discover a Neural Biomarker for OCD

A neural activity pattern has been identified that can accurately predict the clinical state of patients with obsessive-compulsive disorder.

New AI Model Predicts Disease Progression in Early Alzheimer’s Disease

A Predictive Prognostic Model has been developed to predict the rate at which individuals will progress to Alzheimer’s Disease.

Reducing Hot Flashes in Patients with Breast Cancer Using Acupuncture

Acupuncture significantly reduces side effects of endocrine therapy, including hot flashes, in patients with breast cancer.

Risk of Adverse Outcomes with Ventricular Arrhythmias Higher in Women

Women with acute myocardial infarction and ventricular arrhythmias face higher in-hospital mortality and adverse outcomes compared to men

Researchers Identify Key Gene Linked to Vasospastic Angina

The gene RNF213 has been significantly associated with vasospastic angina and increased likelihood of mortality from acute myocardial infarction.

Importance of Early Hepatitis C Screening in Perinatally Exposed Children

A recent study has underscored the critical need for early hepatitis C virus (HCV) screening in children born to HCV-positive mothers.

Influenza Viruses with Reduced Susceptibility to Oseltamivir Detected Globally

Researchers have reported the emergence and spread of influenza A(H1N1)pdm09 viruses with a 13-fold reduced inhibition by oseltamivir.

Ruxolitinib Effective for Steroid-Refractory Graft-Versus-Host Disease

New findings indicate the potential of Ruxolitinib as an effective treatment for steroid-refractory acute graft-versus-host disease.

Plants for Joints Trial: Breaking News from EULAR 2024

Results presented at EULAR 2024, show reductions in DAS28 scores among rheumatoid arthritis patients following a plant-based, whole-food diet, exercise, and stress management regime.

EULAR Breaking News: Interferon Signature in Paediatric Sjögren’s Diagnosis

Researchers presented novel findings on the potential utility of the blood interferon signature in diagnosing and stratifying paediatric Sjögren’s disease.